Expert Opin Pharmacother 2017 Feb;18(3):325-326
Upfront nilotinib therapy among patients with chronic myeloid leukemia in chronic phase.
Eskazan AE1.
Chronic myeloid leukemia; frontline treatment; nilotinib
ukemia; frontline treatment; nilotinib